TITLE

Pharmaceuticals in France

PUB. DATE
November 2004
SOURCE
Pharmaceuticals Industry Profile: France;November 2004, p1
SOURCE TYPE
Industry Profile
DOC. TYPE
Industry Overview
ABSTRACT
Presents a profile of the Pharmaceuticals industry in France. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.
ACCESSION #
15098518

 

Related Articles

  • Pharmaceuticals Industry Profile: Europe.  // Pharmaceuticals Industry Profile: Europe;Dec2005, p1 

    Presents a profile of the Pharmaceuticals industry in Europe. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • Pharmaceuticals Industry Profile: France.  // Pharmaceuticals Industry Profile: France;Dec2005, p1 

    Presents a profile of the Pharmaceuticals industry in France. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • OTC Pharmaceuticals Industry Profile: France.  // OTC Pharmaceuticals Industry Profile: France;Oct2005, p1 

    Presents a profile of the OTC Pharmaceuticals industry in France. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • OTC Pharmaceuticals Industry Profile: France.  // OTC Pharmaceuticals Industry Profile: France;Dec2006, p1 

    Presents a profile of the OTC Pharmaceuticals industry in France. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • Update.  // Medical Marketing & Media;Jun2007, Vol. 42 Issue 6, p17 

    The article reports developments in the pharmaceutical industry in the U.S. The Food and Drug Administration (FDA) was petitioned to approve over-the-counter (OTC) switches for Allegra, Zyrtec and Zyrtec D. Civil investigative demands, which act like subpoenas were issued by the Federal Trade...

  • Pipeline preview.  // Formulary;Oct2005, Vol. 40 Issue 10, p321 

    Reports on drugs in the pipeline for approval by the U.S. Food and Drug Administration. Nelarabine from GlaxoSmithKline for the treatment of T-cell acute lymphoblastic leukemia ad T-cell lymphoblastic lymphoma; Murglitazar from Merck/Bristol-Myers Squibb as monotherapy for type 2 diabetes;...

  • Supplier News.  // Drug Store News;11/21/2005, Vol. 27 Issue 16, p17 

    The article cites news items related to the U.S. pharmaceutical industry as of November 21, 2005. The U.S. Food and Drug Administration (FDA) began requiring drug manufacturers to submit prescription drug label information in a new electronic format. Bristol-Myers Squibb considered abandoning...

  • Pipeline.  // Medical Marketing & Media;Oct2005, Vol. 40 Issue 10, p10 

    Reports on developments related to the pharmaceutical industry in the U.S. Approval of Pfizer Inc.'s Exubera by the Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee; Recommendation for the approval of Bristol-Myers Squibb Co.'s Orencia for the treatment of...

  • Research Capsules.  // Pharmaceutical Representative;May2006, Vol. 36 Issue 5, p13 

    The article reports on the developments in the U.S. pharmaceutical industry. A research suggests that antihypertensives may lessen the risk of Alzheimer's disease after conducting a study on old people. A clinical trial has found out that Bristol-Myers Squibb Co.'s Baraclude may be more...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics